Share Price and Basic Stock Data
Last Updated: December 30, 2025, 9:05 am
| PEG Ratio | 0.44 |
|---|
Analyst Insight & Comprehensive Analysis
AI Stock Ranker – Real-Time Fundamental Strength Score
Business Overview and Revenue Trends
Modi Naturals Ltd operates in the Edible Oils and Solvent Extraction industry, with its stock currently priced at ₹362 and a market capitalization of ₹483 Cr. The company has reported fluctuating sales figures, with a total revenue of ₹418 Cr for the fiscal year ending March 2023, declining from ₹474 Cr in the previous year. However, the trailing twelve months (TTM) revenue rose to ₹671 Cr, indicating a potential recovery and growth trajectory. In the recent quarters, sales peaked at ₹190 Cr in March 2025, showcasing a robust performance compared to ₹110 Cr in March 2023. This restoration in sales reflects a positive trend, especially when juxtaposed against the previous year’s performance, which had seen operational challenges. The company’s ability to achieve a sales increase to ₹663 Cr for the fiscal year ending March 2025 underscores its resilience and adaptability in a competitive market.
Profitability and Efficiency Metrics
Profitability metrics for Modi Naturals Ltd reveal a mixed performance trajectory. The reported operating profit margin (OPM) for the fiscal year ending March 2025 stood at 8%, a significant improvement from just 1% in March 2023. The net profit for March 2025 was ₹31 Cr, recovering from a loss of ₹1 Cr in March 2024. The Earnings Per Share (EPS) also saw a substantial rise, reaching ₹23.32 in March 2025, compared to merely ₹0.85 in March 2023. The interest coverage ratio (ICR) improved to 4.89x, indicating a stronger ability to service debt compared to the previous year’s 1.32x. Furthermore, the return on equity (ROE) and return on capital employed (ROCE) stood at 29.2% and 18.7%, respectively, showcasing efficient use of capital. Overall, these figures suggest a recovering profitability landscape, although ongoing scrutiny of expense management is essential to maintain this momentum.
Balance Sheet Strength and Financial Ratios
Modi Naturals Ltd’s balance sheet reflects both strengths and vulnerabilities. The company’s total borrowings amounted to ₹152 Cr as of September 2025, a notable increase from ₹21 Cr in March 2021. However, the reserves have also grown from ₹55 Cr in March 2021 to ₹129 Cr in September 2025, indicating a strengthening capital base. The debt-to-equity ratio of 1.22x signals a moderate leverage level, although it has increased from 0.30x in March 2021, which could raise concerns over financial risk. The current ratio stood at 1.22x, suggesting adequate liquidity to cover short-term obligations. Additionally, the book value per share rose to ₹91.35, reflecting improved shareholder equity. However, the company needs to manage its debt levels prudently to ensure long-term financial stability while leveraging its growing reserves effectively.
Shareholding Pattern and Investor Confidence
The shareholding pattern of Modi Naturals Ltd indicates a strong promoter holding of 69.09% as of December 2023, which has remained stable over several quarters. This substantial promoter stake is a positive sign, reflecting confidence in the company’s governance and strategic direction. Conversely, foreign institutional investors (FIIs) have not shown interest, and domestic institutional investors (DIIs) have a negligible presence at 0.06% as of December 2023. The public shareholding stood at 30.90%, indicating a diverse shareholder base with 6,634 total shareholders as of September 2025. The relative stability in promoter ownership alongside low institutional participation could suggest a reliance on retail investors for market movements. This aspect may introduce volatility in stock performance, particularly in the absence of institutional backing, which typically provides stability and confidence in market fluctuations.
Outlook, Risks, and Final Insight
Looking ahead, Modi Naturals Ltd faces a blend of opportunities and challenges. The recent upswing in sales and profitability metrics indicates a positive outlook, particularly if the company can sustain its growth trajectory and manage operational efficiencies. However, the increasing debt levels present a significant risk that could impact financial health if not controlled. Additionally, the company’s reliance on domestic markets may expose it to local economic fluctuations and changing consumer preferences, necessitating strategic agility. The absence of institutional investor interest raises concerns about market volatility, which could be exacerbated by economic uncertainties. To navigate these challenges, Modi Naturals Ltd must focus on enhancing operational efficiencies, managing debt prudently, and potentially attracting institutional investors to bolster its market position and investor confidence.
Source: Getaka Fundamental Analysis | Generated using proprietary financial data.
Competitors
| Stock Name ⇩ | Market Cap ⇩ | Current Price ⇩ | High / Low ⇩ | Stock P/E ⇩ | Book Value ⇩ | Dividend Yield ⇩ | ROCE ⇩ | ROE ⇩ | Face Value ⇩ |
|---|---|---|---|---|---|---|---|---|---|
| Modi Naturals Ltd | 481 Cr. | 362 | 610/320 | 13.2 | 107 | 0.00 % | 18.7 % | 29.2 % | 10.0 |
| IEL Ltd | 91.4 Cr. | 7.01 | 10.3/3.87 | 3.37 | 0.00 % | 2.51 % | 1.91 % | 1.00 | |
| Evexia Lifecare Ltd | 310 Cr. | 1.65 | 3.73/1.52 | 217 | 3.02 | 0.00 % | 0.30 % | 0.32 % | 1.00 |
| Diligent Industries Ltd | 64.6 Cr. | 2.71 | 3.95/1.45 | 25.1 | 2.79 | 0.00 % | 7.06 % | 6.09 % | 1.00 |
| CIAN Agro Industries & Infrastructure Ltd | 3,683 Cr. | 1,316 | 3,633/321 | 1,814 | 33.0 | 0.00 % | 8.54 % | 1.06 % | 10.0 |
| Industry Average | 10,498.29 Cr | 172.59 | 144.59 | 37.26 | 0.17% | 14.31% | 12.90% | 4.29 |
Quarterly Result
| Metric | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 100 | 93 | 114 | 110 | 84 | 92 | 104 | 120 | 148 | 147 | 179 | 190 | 155 |
| Expenses | 95 | 91 | 113 | 113 | 81 | 90 | 106 | 114 | 134 | 133 | 166 | 174 | 137 |
| Operating Profit | 5 | 2 | 1 | -2 | 2 | 2 | -1 | 6 | 13 | 13 | 13 | 16 | 18 |
| OPM % | 5% | 2% | 1% | -2% | 3% | 2% | -1% | 5% | 9% | 9% | 7% | 8% | 11% |
| Other Income | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 0 | 0 |
| Interest | 1 | 1 | 1 | 1 | 1 | 1 | 2 | 3 | 3 | 3 | 3 | 3 | 2 |
| Depreciation | 0 | 0 | 0 | 0 | 0 | 0 | 2 | 2 | 2 | 2 | 2 | 2 | 2 |
| Profit before tax | 3 | 1 | 0 | -3 | 1 | 1 | -5 | 1 | 9 | 9 | 9 | 11 | 13 |
| Tax % | 25% | 25% | 0% | -13% | 16% | 16% | -15% | 6% | 14% | 15% | 12% | 27% | 22% |
| Net Profit | 3 | 1 | 0 | -2 | 1 | 1 | -4 | 1 | 7 | 8 | 8 | 8 | 10 |
| EPS in Rs | 2.06 | 0.60 | 0.01 | -1.83 | 0.62 | 0.60 | -3.20 | 0.96 | 5.70 | 5.79 | 5.97 | 6.23 | 8.01 |
Last Updated: August 19, 2025, 12:55 pm
Below is a detailed analysis of the quarterly data for Modi Naturals Ltd based on the most recent figures (Jun 2025) and their trends compared to the previous period:
- For Sales, as of Jun 2025, the value is 155.00 Cr.. The value appears to be declining and may need further review. It has decreased from 190.00 Cr. (Mar 2025) to 155.00 Cr., marking a decrease of 35.00 Cr..
- For Expenses, as of Jun 2025, the value is 137.00 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 174.00 Cr. (Mar 2025) to 137.00 Cr., marking a decrease of 37.00 Cr..
- For Operating Profit, as of Jun 2025, the value is 18.00 Cr.. The value appears strong and on an upward trend. It has increased from 16.00 Cr. (Mar 2025) to 18.00 Cr., marking an increase of 2.00 Cr..
- For OPM %, as of Jun 2025, the value is 11.00%. The value appears strong and on an upward trend. It has increased from 8.00% (Mar 2025) to 11.00%, marking an increase of 3.00%.
- For Other Income, as of Jun 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 0.00 Cr..
- For Interest, as of Jun 2025, the value is 2.00 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 3.00 Cr. (Mar 2025) to 2.00 Cr., marking a decrease of 1.00 Cr..
- For Depreciation, as of Jun 2025, the value is 2.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 2.00 Cr..
- For Profit before tax, as of Jun 2025, the value is 13.00 Cr.. The value appears strong and on an upward trend. It has increased from 11.00 Cr. (Mar 2025) to 13.00 Cr., marking an increase of 2.00 Cr..
- For Tax %, as of Jun 2025, the value is 22.00%. The value appears to be improving (decreasing) as expected. It has decreased from 27.00% (Mar 2025) to 22.00%, marking a decrease of 5.00%.
- For Net Profit, as of Jun 2025, the value is 10.00 Cr.. The value appears strong and on an upward trend. It has increased from 8.00 Cr. (Mar 2025) to 10.00 Cr., marking an increase of 2.00 Cr..
- For EPS in Rs, as of Jun 2025, the value is 8.01. The value appears strong and on an upward trend. It has increased from 6.23 (Mar 2025) to 8.01, marking an increase of 1.78.
Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.
Profit & Loss - Annual Report
Last Updated: December 15, 2025, 3:28 am
| Metric | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM |
|---|---|---|---|---|---|---|
| Sales | 443 | 474 | 418 | 399 | 663 | 671 |
| Expenses | 430 | 459 | 412 | 390 | 607 | 608 |
| Operating Profit | 13 | 15 | 5 | 9 | 56 | 62 |
| OPM % | 3% | 3% | 1% | 2% | 8% | 9% |
| Other Income | 4 | 1 | 2 | 1 | 1 | 2 |
| Interest | 1 | 2 | 4 | 7 | 12 | 11 |
| Depreciation | 1 | 1 | 2 | 4 | 8 | 8 |
| Profit before tax | 14 | 13 | 2 | -2 | 38 | 45 |
| Tax % | 25% | 28% | 42% | -21% | 18% | |
| Net Profit | 11 | 9 | 1 | -1 | 31 | 37 |
| EPS in Rs | 8.31 | 7.40 | 0.85 | -1.04 | 23.32 | 27.46 |
| Dividend Payout % | -0% | -0% | -0% | -0% | -0% |
YoY Net Profit Growth
| Year | 2021-2022 | 2022-2023 | 2023-2024 | 2024-2025 |
|---|---|---|---|---|
| YoY Net Profit Growth (%) | -18.18% | -88.89% | -200.00% | 3200.00% |
| Change in YoY Net Profit Growth (%) | 0.00% | -70.71% | -111.11% | 3400.00% |
Modi Naturals Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 4 years from 2021-2022 to 2024-2025.
Growth
| Compounded Sales Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | 12% |
| TTM: | 45% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | 49% |
| TTM: | 544% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 27% |
| 5 Years: | 53% |
| 3 Years: | 33% |
| 1 Year: | 53% |
| Return on Equity | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | 11% |
| Last Year: | 29% |
Last Updated: September 5, 2025, 3:51 pm
Balance Sheet
Last Updated: December 4, 2025, 3:08 am
| Month | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Sep 2025 |
|---|---|---|---|---|---|---|
| Equity Capital | 13 | 13 | 13 | 13 | 13 | 13 |
| Reserves | 55 | 65 | 69 | 77 | 108 | 129 |
| Borrowings | 21 | 51 | 142 | 170 | 149 | 152 |
| Other Liabilities | 33 | 37 | 38 | 46 | 59 | 59 |
| Total Liabilities | 121 | 165 | 263 | 306 | 330 | 353 |
| Fixed Assets | 19 | 26 | 27 | 149 | 145 | 141 |
| CWIP | 0 | 0 | 91 | 0 | 16 | 54 |
| Investments | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Assets | 102 | 139 | 144 | 157 | 169 | 158 |
| Total Assets | 121 | 165 | 263 | 306 | 330 | 353 |
Below is a detailed analysis of the balance sheet data for Modi Naturals Ltd based on the most recent figures (Sep 2025) and their trends compared to the previous period:
- For Equity Capital, as of Sep 2025, the value is 13.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 13.00 Cr..
- For Reserves, as of Sep 2025, the value is 129.00 Cr.. The value appears strong and on an upward trend. It has increased from 108.00 Cr. (Mar 2025) to 129.00 Cr., marking an increase of 21.00 Cr..
- For Borrowings, as of Sep 2025, the value is 152.00 Cr.. The value appears to be increasing, which may not be favorable. However, Borrowings exceed Reserves, which may signal higher financial risk. It has increased from 149.00 Cr. (Mar 2025) to 152.00 Cr., marking an increase of 3.00 Cr..
- For Other Liabilities, as of Sep 2025, the value is 59.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 59.00 Cr..
- For Total Liabilities, as of Sep 2025, the value is 353.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 330.00 Cr. (Mar 2025) to 353.00 Cr., marking an increase of 23.00 Cr..
- For Fixed Assets, as of Sep 2025, the value is 141.00 Cr.. The value appears to be declining and may need further review. It has decreased from 145.00 Cr. (Mar 2025) to 141.00 Cr., marking a decrease of 4.00 Cr..
- For CWIP, as of Sep 2025, the value is 54.00 Cr.. The value appears strong and on an upward trend. It has increased from 16.00 Cr. (Mar 2025) to 54.00 Cr., marking an increase of 38.00 Cr..
- For Investments, as of Sep 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 0.00 Cr..
- For Other Assets, as of Sep 2025, the value is 158.00 Cr.. The value appears to be declining and may need further review. It has decreased from 169.00 Cr. (Mar 2025) to 158.00 Cr., marking a decrease of 11.00 Cr..
- For Total Assets, as of Sep 2025, the value is 353.00 Cr.. The value appears strong and on an upward trend. It has increased from 330.00 Cr. (Mar 2025) to 353.00 Cr., marking an increase of 23.00 Cr..
However, the Borrowings (152.00 Cr.) are higher than the Reserves (129.00 Cr.), which may signal higher financial risk.
Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.
Cash Flow
| Month | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|
Free Cash Flow
| Month | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|
| Free Cash Flow | -8.00 | -36.00 | -137.00 | -161.00 | -93.00 |
Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)
Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.
Financial Efficiency Indicators
| Month | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|
| Debtor Days | 17 | 15 | 17 | 25 | 26 |
| Inventory Days | 72 | 95 | 98 | 125 | 60 |
| Days Payable | 8 | 12 | 21 | 33 | 20 |
| Cash Conversion Cycle | 81 | 98 | 94 | 117 | 66 |
| Working Capital Days | 42 | 34 | 37 | 26 | 14 |
| ROCE % | 14% | 3% | 3% | 19% |
This stock is not held by any mutual fund.
Key Financial Ratios
| Month | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 |
|---|---|---|---|---|---|
| FaceValue | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
| Basic EPS (Rs.) | 23.25 | -0.89 | 0.93 | 7.38 | 8.31 |
| Diluted EPS (Rs.) | 23.25 | -0.89 | 0.93 | 7.38 | 8.31 |
| Cash EPS (Rs.) | 29.19 | 2.13 | 2.07 | 8.52 | 9.40 |
| Book Value[Excl.RevalReserv]/Share (Rs.) | 91.35 | 68.10 | 64.59 | 61.00 | 53.62 |
| Book Value[Incl.RevalReserv]/Share (Rs.) | 91.35 | 68.10 | 64.59 | 61.00 | 53.62 |
| Revenue From Operations / Share (Rs.) | 498.19 | 300.47 | 330.24 | 374.75 | 349.78 |
| PBDIT / Share (Rs.) | 43.00 | 7.68 | 5.49 | 12.78 | 13.15 |
| PBIT / Share (Rs.) | 37.12 | 4.51 | 4.26 | 11.66 | 12.06 |
| PBT / Share (Rs.) | 28.33 | -1.30 | 1.47 | 10.23 | 11.04 |
| Net Profit / Share (Rs.) | 23.32 | -1.03 | 0.84 | 7.40 | 8.31 |
| NP After MI And SOA / Share (Rs.) | 23.32 | -1.03 | 0.84 | 7.40 | 8.31 |
| PBDIT Margin (%) | 8.63 | 2.55 | 1.66 | 3.41 | 3.75 |
| PBIT Margin (%) | 7.45 | 1.50 | 1.28 | 3.11 | 3.44 |
| PBT Margin (%) | 5.68 | -0.43 | 0.44 | 2.73 | 3.15 |
| Net Profit Margin (%) | 4.68 | -0.34 | 0.25 | 1.97 | 2.37 |
| NP After MI And SOA Margin (%) | 4.68 | -0.34 | 0.25 | 1.97 | 2.37 |
| Return on Networth / Equity (%) | 25.52 | -1.52 | 1.30 | 12.13 | 15.49 |
| Return on Capital Employeed (%) | 24.71 | 3.32 | 3.09 | 17.91 | 20.85 |
| Return On Assets (%) | 9.40 | -0.45 | 0.40 | 5.66 | 8.67 |
| Long Term Debt / Equity (X) | 0.58 | 0.94 | 1.07 | 0.00 | 0.00 |
| Total Debt / Equity (X) | 1.22 | 1.87 | 1.74 | 0.66 | 0.30 |
| Asset Turnover Ratio (%) | 2.08 | 1.41 | 1.95 | 3.31 | 0.00 |
| Current Ratio (X) | 1.22 | 1.24 | 1.53 | 1.59 | 2.06 |
| Quick Ratio (X) | 0.57 | 0.47 | 0.57 | 0.46 | 0.64 |
| Inventory Turnover Ratio (X) | 7.37 | 4.43 | 3.61 | 4.70 | 0.00 |
| Interest Coverage Ratio (X) | 4.89 | 1.32 | 1.97 | 8.96 | 12.85 |
| Interest Coverage Ratio (Post Tax) (X) | 3.65 | 0.82 | 1.30 | 6.19 | 9.12 |
| Enterprise Value (Cr.) | 601.08 | 422.48 | 433.31 | 295.48 | 112.19 |
| EV / Net Operating Revenue (X) | 0.90 | 1.06 | 1.04 | 0.62 | 0.25 |
| EV / EBITDA (X) | 10.51 | 41.33 | 62.37 | 18.26 | 6.74 |
| MarketCap / Net Operating Revenue (X) | 0.68 | 0.63 | 0.70 | 0.52 | 0.20 |
| Price / BV (X) | 3.75 | 2.81 | 3.61 | 3.23 | 1.36 |
| Price / Net Operating Revenue (X) | 0.68 | 0.63 | 0.70 | 0.52 | 0.20 |
| EarningsYield | 0.06 | -0.01 | 0.00 | 0.03 | 0.11 |
After reviewing the key financial ratios for Modi Naturals Ltd, here is a detailed analysis based on the latest available data and recent trends:
- For FaceValue, as of Mar 25, the value is 10.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 10.00.
- For Basic EPS (Rs.), as of Mar 25, the value is 23.25. This value is within the healthy range. It has increased from -0.89 (Mar 24) to 23.25, marking an increase of 24.14.
- For Diluted EPS (Rs.), as of Mar 25, the value is 23.25. This value is within the healthy range. It has increased from -0.89 (Mar 24) to 23.25, marking an increase of 24.14.
- For Cash EPS (Rs.), as of Mar 25, the value is 29.19. This value is within the healthy range. It has increased from 2.13 (Mar 24) to 29.19, marking an increase of 27.06.
- For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 91.35. It has increased from 68.10 (Mar 24) to 91.35, marking an increase of 23.25.
- For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 91.35. It has increased from 68.10 (Mar 24) to 91.35, marking an increase of 23.25.
- For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 498.19. It has increased from 300.47 (Mar 24) to 498.19, marking an increase of 197.72.
- For PBDIT / Share (Rs.), as of Mar 25, the value is 43.00. This value is within the healthy range. It has increased from 7.68 (Mar 24) to 43.00, marking an increase of 35.32.
- For PBIT / Share (Rs.), as of Mar 25, the value is 37.12. This value is within the healthy range. It has increased from 4.51 (Mar 24) to 37.12, marking an increase of 32.61.
- For PBT / Share (Rs.), as of Mar 25, the value is 28.33. This value is within the healthy range. It has increased from -1.30 (Mar 24) to 28.33, marking an increase of 29.63.
- For Net Profit / Share (Rs.), as of Mar 25, the value is 23.32. This value is within the healthy range. It has increased from -1.03 (Mar 24) to 23.32, marking an increase of 24.35.
- For NP After MI And SOA / Share (Rs.), as of Mar 25, the value is 23.32. This value is within the healthy range. It has increased from -1.03 (Mar 24) to 23.32, marking an increase of 24.35.
- For PBDIT Margin (%), as of Mar 25, the value is 8.63. This value is below the healthy minimum of 10. It has increased from 2.55 (Mar 24) to 8.63, marking an increase of 6.08.
- For PBIT Margin (%), as of Mar 25, the value is 7.45. This value is below the healthy minimum of 10. It has increased from 1.50 (Mar 24) to 7.45, marking an increase of 5.95.
- For PBT Margin (%), as of Mar 25, the value is 5.68. This value is below the healthy minimum of 10. It has increased from -0.43 (Mar 24) to 5.68, marking an increase of 6.11.
- For Net Profit Margin (%), as of Mar 25, the value is 4.68. This value is below the healthy minimum of 5. It has increased from -0.34 (Mar 24) to 4.68, marking an increase of 5.02.
- For NP After MI And SOA Margin (%), as of Mar 25, the value is 4.68. This value is below the healthy minimum of 8. It has increased from -0.34 (Mar 24) to 4.68, marking an increase of 5.02.
- For Return on Networth / Equity (%), as of Mar 25, the value is 25.52. This value is within the healthy range. It has increased from -1.52 (Mar 24) to 25.52, marking an increase of 27.04.
- For Return on Capital Employeed (%), as of Mar 25, the value is 24.71. This value is within the healthy range. It has increased from 3.32 (Mar 24) to 24.71, marking an increase of 21.39.
- For Return On Assets (%), as of Mar 25, the value is 9.40. This value is within the healthy range. It has increased from -0.45 (Mar 24) to 9.40, marking an increase of 9.85.
- For Long Term Debt / Equity (X), as of Mar 25, the value is 0.58. This value is within the healthy range. It has decreased from 0.94 (Mar 24) to 0.58, marking a decrease of 0.36.
- For Total Debt / Equity (X), as of Mar 25, the value is 1.22. This value exceeds the healthy maximum of 1. It has decreased from 1.87 (Mar 24) to 1.22, marking a decrease of 0.65.
- For Asset Turnover Ratio (%), as of Mar 25, the value is 2.08. It has increased from 1.41 (Mar 24) to 2.08, marking an increase of 0.67.
- For Current Ratio (X), as of Mar 25, the value is 1.22. This value is below the healthy minimum of 1.5. It has decreased from 1.24 (Mar 24) to 1.22, marking a decrease of 0.02.
- For Quick Ratio (X), as of Mar 25, the value is 0.57. This value is below the healthy minimum of 1. It has increased from 0.47 (Mar 24) to 0.57, marking an increase of 0.10.
- For Inventory Turnover Ratio (X), as of Mar 25, the value is 7.37. This value is within the healthy range. It has increased from 4.43 (Mar 24) to 7.37, marking an increase of 2.94.
- For Interest Coverage Ratio (X), as of Mar 25, the value is 4.89. This value is within the healthy range. It has increased from 1.32 (Mar 24) to 4.89, marking an increase of 3.57.
- For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 3.65. This value is within the healthy range. It has increased from 0.82 (Mar 24) to 3.65, marking an increase of 2.83.
- For Enterprise Value (Cr.), as of Mar 25, the value is 601.08. It has increased from 422.48 (Mar 24) to 601.08, marking an increase of 178.60.
- For EV / Net Operating Revenue (X), as of Mar 25, the value is 0.90. This value is below the healthy minimum of 1. It has decreased from 1.06 (Mar 24) to 0.90, marking a decrease of 0.16.
- For EV / EBITDA (X), as of Mar 25, the value is 10.51. This value is within the healthy range. It has decreased from 41.33 (Mar 24) to 10.51, marking a decrease of 30.82.
- For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 0.68. This value is below the healthy minimum of 1. It has increased from 0.63 (Mar 24) to 0.68, marking an increase of 0.05.
- For Price / BV (X), as of Mar 25, the value is 3.75. This value exceeds the healthy maximum of 3. It has increased from 2.81 (Mar 24) to 3.75, marking an increase of 0.94.
- For Price / Net Operating Revenue (X), as of Mar 25, the value is 0.68. This value is below the healthy minimum of 1. It has increased from 0.63 (Mar 24) to 0.68, marking an increase of 0.05.
- For EarningsYield, as of Mar 25, the value is 0.06. This value is below the healthy minimum of 5. It has increased from -0.01 (Mar 24) to 0.06, marking an increase of 0.07.
Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.
Strength and Weakness
| Strength | Weakness |
|---|---|
|
|
Stock Analysis
- Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in Modi Naturals Ltd:
- Net Profit Margin: 4.68%
- Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
- ROCE: 24.71% (Industry Average ROCE: 14.31%)
- ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
- ROE%: 25.52% (Industry Average ROE: 12.9%)
- ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
- Interest Coverage Ratio (Post Tax): 3.65
- Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
- Quick Ratio: 0.57
- Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
- Stock P/E: 13.2 (Industry average Stock P/E: 144.59)
- Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
- Total Debt / Equity: 1.22
- Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
Stock Rating: - Net Profit Margin: 4.68%
About the Company - Qualitative Analysis
| INDUSTRY | ADDRESS | CONTACT |
|---|---|---|
| Edible Oils & Solvent Extraction | 405, Deepali Building, New Delhi Delhi 110019 | Contact not found |
| Management | |
|---|---|
| Name | Position Held |
| Mr. Anil Modi | Chairman & Managing Director |
| Mr. Akshay Modi | Joint Managing Director |
| Mrs. Aditi Modi | Whole Time Director |
| Mr. Ankit Garg | Independent Director |
| Mrs. Ankita Singal | Independent Director |
| Mr. Udit Jain | Independent Director |
FAQ
What is the intrinsic value of Modi Naturals Ltd?
Modi Naturals Ltd's intrinsic value (as of 30 December 2025) is 336.54 which is 7.03% lower the current market price of 362.00, indicating overvalued. Calculated using the PE ratio method, this valuation considers the company's 481 Cr. market cap, FY2025-2026 high/low of 610/320, reserves of ₹129 Cr, and liabilities of 353 Cr.
What is the Market Cap of Modi Naturals Ltd?
The Market Cap of Modi Naturals Ltd is 481 Cr..
What is the current Stock Price of Modi Naturals Ltd as on 30 December 2025?
The current stock price of Modi Naturals Ltd as on 30 December 2025 is 362.
What is the High / Low of Modi Naturals Ltd stocks in FY 2025-2026?
In FY 2025-2026, the High / Low of Modi Naturals Ltd stocks is 610/320.
What is the Stock P/E of Modi Naturals Ltd?
The Stock P/E of Modi Naturals Ltd is 13.2.
What is the Book Value of Modi Naturals Ltd?
The Book Value of Modi Naturals Ltd is 107.
What is the Dividend Yield of Modi Naturals Ltd?
The Dividend Yield of Modi Naturals Ltd is 0.00 %.
What is the ROCE of Modi Naturals Ltd?
The ROCE of Modi Naturals Ltd is 18.7 %.
What is the ROE of Modi Naturals Ltd?
The ROE of Modi Naturals Ltd is 29.2 %.
What is the Face Value of Modi Naturals Ltd?
The Face Value of Modi Naturals Ltd is 10.0.